U.S. market Open. Closes in 48 seconds

TBPH | Theravance Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue57.42M51.35M55.31M71.86M73.41M60.37M15.39M48.65M42.13M11.69M226.00K130.15M
Cost of Revenue6.05M6.59M7.29M260.95M219.25M715.00K6.03M2.89M4.66M4.06MN/AN/A
Gross Profit51.37M44.76M48.02M-189.10M-145.83M59.66M9.36M45.75M37.47M7.63M226.00K130.15M
Operating Expenses110.72M130.47M292.95M369.61M325.33M298.41M269.48M226.22M219.37M240.17M156.51M139.72M
Selling, General & Admin70.09M67.07M99.30M108.66M106.08M97.06M95.59M84.51M90.20M71.65MN/AN/A
Research & Development40.62M63.39M193.66M260.95M219.25M201.35M173.89M141.71M129.16M168.52M120.58M114.00M
Other Operating ExpensesN/AN/AN/A-1.61MN/AN/AN/AN/AN/AN/A35.93M25.73M
Operating Income-53.29M-91.96M-257.78M-297.76M-251.91M-238.75M-260.12M-180.47M-181.90M-232.54M-156.28M-9.57M
Other Expenses / Income4.02M-858.00K58.21M11.22M10.24M11.18M-11.59M-92.00K631.00K1.86MN/AN/A
Before Tax Income-49.27M-92.81M-199.58M-286.54M-241.68M-226.09M-271.71M-180.56M-181.27M-230.67M-156.28M-9.57M
Income Tax Expenses5.92M9.00K-151.00K-8.52M-5.22M-10.56M13.69M10.11M951.00K6.36MN/AN/A
Net Income-55.19M-92.82M-199.43M-278.02M-236.46M-215.52M-285.40M-190.67M-182.22M-237.04M-156.28M-9.57M
Interest Expenses2.35M6.37M46.89M44.59M31.86M10.48M8.55M1.40MN/AN/AN/AN/A
Basic Shares Outstanding55.30M73.59M69.46M62.34M55.61M53.97M52.35M44.71M34.15M31.75M32.26M32.26M
Diluted Shares Outstanding55.30M73.59M69.46M62.34M55.61M53.97M52.35M44.71M34.15M31.75M32.26M32.26M
EBITDA-40.28M-70.57M-132.55M-226.49M-209.81M-215.60M-259.14M-176.04M-178.28M-228.01M-153.63M-6.32M
EBITDA Margin-70.14%-137.45%-239.64%-315.19%-285.80%-357.14%-1,684.24%-361.86%-423.20%-1,950.82%-67,978.32%-4.86%
EBIT-46.92M-86.45M-152.69M-241.95M-209.81M-215.60M-263.16M-179.16M-181.27M-230.67M-156.28M-9.57M
EBIT Margin-81.71%-168.36%-276.05%-336.71%-285.80%-357.14%-1,710.41%-368.27%-430.30%-1,973.60%-69,152.21%-7.36%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙